Library

Last modification: 2024/11/04 https://kinderkrebsinfo.de/doi/e8952

Autor(en) Titel Quelle Links
Kaatsch P, Michaelis J Epidemiological data on childhood malignancies in the first year of life. Contrib Oncol 1990, 41: 1    
Kaatsch P, Haaf G, Michaelis J Empfehlungen zur Vorgehensweise bei vermuteten regionalen Häufungen von Krebserkrankungen. Europäische Perspektiven der Medizinischen Informatik, Biometrie und Epidemiologie 1993, 33    
Kaatsch P, Haaf G, Michaelis J Childhood malignancies in Germany - methods and results of a nationwide registry. Eur J Cancer 1995, 31A: 993    
Kaatsch P, Haaf G, Michaelis J Haben Krebserkrankungen im Kindesalter zugenommen? Monatsschrift Kinderheilkunde 1995, 143: 554    
Kaatsch P, Michaelis J Wie oft Kinder krank werden. Leben will ich jeden Tag 1995, 22    
Kaatsch P, Michaelis J Second neoplasms after malignant diseases in childhood. Klin Pädiatr 1995, 207: 158    
Kaatsch P, Michaelis J Second neoplasms after malignant diseases in childhood. Klin Pädiatr 1995, 207: 158    
Kaatsch P, Kaletsch U, Krummenauer F, Meinert R, Miesner A, Haaf G, Michaelis J Case control study on childhood leukemia in Lower Saxony, Germany. Basic considerations, methodology, and summary of results. Klin Pädiatr 1996, 208: 179    
Kaatsch P, Kaletsch U, Meinert R, Michaelis J An extended study on childhood malignancies in the vicinity of German nuclear power plants. Cancer Causes Control 1998, 9: 529    
Kaatsch P, Kaletsch U, Meinert R, Miesner A, Hoisl M, Schuz J, Michaelis J German case control study on childhood leukaemia--basic considerations, methodology and summary of the results. Klin Pädiatr 1998, 210: 185    
Kaatsch P Studien des Deutschen Kinderkrebsregisters zum Auftreten von Leukämien und anderen Krebserkrankungen bei Kindern. Forum Deutsche Krebsgesellschaft 1999, 300    
Kaatsch P, Rickert C, Kühl J, Schuz J, Michaelis J Population-based epidemiologic data on brain tumors in German children. Cancer 2001, 92: 3155    
Kaatsch P Das Deutsche Kinderkrebsregister zwei Jahrzehnte nach Beginn seiner Tätigkeit. Monatsschr Kinderheilkd 2002, 150: 966    
Kaatsch P, Klein G, Schulz B, Spix C Epidemiological data on secondary malignant neoplasms after childhood cancer in Germany [Abstract]. Med Ped Oncol 2002, 39: 254    
Kaatsch P, Schüz J Epidemiologische Studien zu politisch kontrovers diskutierten Themen und deren Kommunikation in die Öffentlichkeit - Empfehlungen zur Risikokommunikation. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 2002, 83    
Kaatsch P, Spix C, Michaelis J German Childhood Cancer Registry - Annual Report 2000 (Jahresbericht 2000 des Deutschen Kinderkrebsregisters).    
Kaaijk P, Kaspers G, van Wering E, Broekema G, Loonen A, Hahlen K, Schmiegelow K, Janka-Schaub G, Henze G, Creutzig U, Veerman A Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Br J Cancer 2003, 88: 775    
Kaatsch P German Childhood Cancer Registry and its favorable setting. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004, 47: 437    
Kaatsch P, Blettner M Das Langzeit-follow-up in der deutschen pädiatrischen Onkologie als Grundlage für Studien mit Langzeitüberlebenden. Monatsschr Kinderheilkd 2004, 152    
Kaatsch P, Spix C German Childhood Cancer Registry - Annual Report 2003 (Jahresbericht 2003 des Deutschen Kinderkrebsregisters).    
Kaatsch P, Spix C Jahresbericht 2004 des Deutschen Kinderkrebsregisters. Technischer Bericht, Universität Mainz 2005    
Kaatsch P, Blettner M, Spix C, Jürgens H Follow up of long-term survivors after childhood cancer in Germany. Klinische Pädiatrie 2005, 217: 169    
Kaatsch P Deutsches Kinderkrebsregister - Eine international angesehene Datenquelle. Dtsch Arztebl 102: A1421-22, 2005    
Kaatsch P, Spix C, Schüz J Epidemiologie, Ätiologie, Prävention. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J (Hrsg): Pädiatrische Hämatologie und Onkologie, S. 421-35 Springer Medizin Verlag Heidelberg. 2005    
Kaatsch P 25 Jahre Deutsches Kinderkrebsregister: Langzeitfolgen rücken ins Blickfeld - Nehmen Krebserkrankungen bei Kindern zu? WIR-Informationsschrift von DLFH-Dachverband und Aktion für krebskranke Kinder e.V. (Bonn) 2005, 3    
Kaatsch P, Spix C German Childhood Cancer Registry - Annual Report 2005 (Jahresbericht 2005 des Deutschen Kinderkrebsregisters). Technischer Bericht, Universität Mainz 2006    
Kaatsch P, Spix C Registry - Annual Report 2006/07 (Jahresbericht 2006/07 des Deutschen Kinderkrebsregisters). Technischer Bericht, Universität Mainz    
Kaatsch P, Spix C, Schulze-Rath R, Schmiedel S, Blettner M Leukaemia in young children living in the vicinity of German nuclear power plants. International journal of cancer. Journal international du cancer 2008, 122: 721    
Kaatsch P, Spix C Registry - Annual Report 2008 (Jahresbericht 2008 des Deutschen Kinderkrebsregisters). Technischer Bericht, Universität Mainz 2008    
Kaatsch P, Spix C, Jung I, Blettner M Childhood leukemia in the vicinity of nuclear power plants in Germany. Deutsches Arzteblatt international 2008, 105: 725    
Kaatsch P, Reinisch I, Spix C, Berthold F, Janka-Schaub G, Mergenthaler A, Michaelis J, Blettner M Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany. Cancer causes & control 2009, 20: 965    
Kaatsch P, Debling D, Blettner M, Spix C Second malignant neoplasms after childhood cancer in Germany - results from the long-term follow-up of the German Childhood Cancer Registry. Strahlentherapie und Onkologie 2009, 185 Suppl 2: 8    
Kaatsch P, Scheidemann-Wesp U, Schüz J Maternal use of antibiotics and cancer in the offspring: results of a case-control study in Germany. Cancer causes & control 2010    
Kaatsch P, Spix C Jahresbericht 2011. Deutsches Kinderkrebsregister, Universitätsmedizin der Johannes Gutenberg-Universität Mainz 2011    
Kaatsch P, Spix C German Childhood Cancer Registry - Report 2012 (1980-2012) (Jahresbericht Deutsches Kinderkrebsregister 2012). Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin der Johannes Gutenberg-Universität Mainz 2013    
Kaatsch P, Spix C German Childhood Cancer Registry - Jahresbericht / Annual Report 2013/14 (1980-2013). Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin der Johannes Gutenberg-Universität Mainz 2014    
Kaatsch P, Häfner C, Calaminus G, Blettner M, Tulla M Pediatric germ cell tumors from 1987 to 2011: incidence rates, time trends, and survival. Pediatrics 2015, 135:e136    
Kaatsch P, Spix C German Childhood Cancer Registry - Jahresbericht / Annual Report 2015 (1980-2014). Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin der Johannes Gutenberg-Universität Mainz 2015    
Kaatsch P, Grabow D, Spix C German Childhood Cancer Registry - Jahresbericht / Annual Report 2016 (1980-2015). Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin der Johannes Gutenberg-Universität Mainz 2016    
Kaatsch P, Strothotte J, Becker C, Bielack S, Dirksen U, Blettner M Pediatric bone tumors in Germany from 1987 to 2011: incidence rates, time trends and survival. Acta oncologica (Stockholm, Sweden) 2016 Sep - Oct; 55(9-10): 1145    
Kaatsch P, Grabow D, Spix C German Childhood Cancer Registry - Annual Report 2017 (1980-2016). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz, 2018    
Kaatsch P Epidemiologie von Krebserkrankungen im Kindesalter, in: Niemeyer CH, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie 2018, 2. Aufl.: 163    
Kaatsch P, Grabow D, Spix C German Childhood Cancer Registry - Anual Report 2018 (1980-2017). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz 2019    
Kager L, Heise A, Minkov M, Mobius D, Kotte W, Schulte-Overberg U, Henze G, Gadner H Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis. Pediatr Hematol Oncol 1999, 16: 251    
Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack S Primary metastatic osteosarcoma. J Clin Oncol 2003, 21: 2011    
Kager L, Zoubek A, Dominkus M, Lang S, Bodmer N, Jundt G, Klingebiel T, Jürgens H, Gadner H, Bielack S, for the COSS Study Group Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group. Cancer 2010,    
Kager L, Kempf-Bielack B, Bielack S Synchronous and metachronous lung metastases in high-grade osteosarcoma. Japanese journal of clinical oncology 2010, 40: 94    
Kager L, Pötschger U, Bielack S Review of mifamurtide in the treatment of patients with osteosarcoma. Ther Clin Risk Manag 2010, 24; 6: 279    
Kager L, Zoubek A, Dominkus M, Lang S, Bodmer N, Jundt G, Klingebiel T, Jürgens H, Gadner H, Bielack S, COSS Study Group Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group. Cancer 2010, 116: 5316    
Kager L, Bielack S [Chemotherapeutic concepts for bone sarcomas]. Der Unfallchirurg 2014, 117: 517    
Kager L, Tamamyan G, Bielack S Novel insights and therapeutic interventions for pediatric osteosarcoma. Future oncology (London, England) 2017, 13: 357    
Kager L, Bielack S Osteosarkome. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie, Springer-Verlag GmbH Deutschland 2. vollständig überarbeitete Auflage 2018, 509    
Kahle W (Hrsg) Taschenatlas der Anatomie für Studium und Praxis: 3, Nervensystem und Sinnesorgane. Georg-Thieme-Verlag 6. überarbeitete Aufl. 1991    
Kaiser I, Kauertz K, Zöllner SK, Hartmann W, Langer T, Jürgens H, Ranft A, Dirksen U Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry. Cancers 2022, 14    
Kaletsch U, Kaatsch P, Meinert R, Schuz J, Czarwinski R, Michaelis J Childhood cancer and residential radon exposure - results of a population-based case-control study in Lower Saxony (Germany). Radiat Environ Biophys 1999, 38: 211    
Kallage V, Müller J, Zimmermann M, Beck J, Ritter J, Creutzig U Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87. Klin Pädiatr 1999, 211: 250    
Kalden J, Eger, G Greten, H et altri (Hrsg.): Innere Medizin: Erhöhte Infektanfälligkeit-primäre und sekundäre Immundefekte. Thieme Verlag 2010    
Kalden J, Eger, G Erhöhte Infektanfälligkeit - primäre und sekundäre Immundefekte. Greten, K et al. (Hrsg.): Innere Medizin 2910    
Kamps W, Bokkerink J, Hahlen K, Hermans J, Riehm H, Gadner H, Schrappe M, Slater R, Ruiter van, Smets L, de Vaan G, Weening R, van Weerden J, van Wering E, Berg den Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy. Blood 1999, 94: 1226    
Kampers J, Orjuela-Grimm M, Schober T, Schulz TF, Stiefel M, Klein C, Körholz D, Mauz-Körholz C, Kreipe H, Beier R, Maecker-Kolhoff B Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leukemia & lymphoma 2017, 58: 633    
Kanitz JL, Pretzer K, Calaminus G, Wiener A, Längler A, Henze G, Driever PH, Seifert G Eurythmy therapy in the aftercare of pediatric posterior fossa tumour survivors--a pilot study. Complementary therapies in medicine 2013, 21 Suppl 1:S3    
Kappler R, von Schweinitz D A better way forward: targeting hedgehog signaling in liver cancer. Frontiers in bioscience 2012, 4: 277    
Karthaus M, Wolf H, Egerer G, Kämpfe D, Ritter J, Jürgens H Ceftriaxone in the treatment of solid tumor patients with febrile neutropenia. Onkologie, International Journal for Cancer Treatment and Therapy 1998, 21: 212    
Karawajew L, Ruppert V, Wuchter C, Kosser A, Schrappe M, Dorken B, Ludwig W Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia. Blood 2000, 96: 297    
Karajannis M, Hummel M, Oschlies I, Anagnostopoulos I, Zimmermann M, Stein H, Parwaresch R, Reiter A Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas. Blood 2003, 102    
Kardos G, Baumann I, Passmore S, Locatelli F, Hasle H, Schultz K, Stary J, Schmitt-Graeff A, Fischer A, Harbott J, Chessells J, Hann I, Fenu S, Rajnoldi A, Kerndrup G, van Wering E, Rogge T, Nollke P, Niemeyer C Refractory anemia in childhood. Blood 2003, 102: 1997    
Karachunskiy A, Herold R, von Stackelberg A, Miakova N, Timakow A, Mahortih T, Bajdun L, Maschan A, Fechina L, Shamardina A, Dudkin S, Lebedev V, Varfolomeeva S, Timofeeva V, Roumiantseva J, Chipsanova N, Rumjanzew A, Henze G Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia 2008, 22: 1144    
Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff JE, Kramm CM Pediatric giant cell glioblastoma: New insights into a rare tumor entity. Neuro-oncology 2009, 11: 323    
Karow A, Baumann I, Niemeyer CM Morphologic differential diagnosis of juvenile myelomonocytic leukemia--pitfalls apart from viral infection. Journal of pediatric hematology/oncology 2009, 31: 380    
Karremann M, Pietsch T, Janssen G, Kramm CM, Wolff JE Anaplastic ganglioglioma in children. J Neurooncol 2009, 92: 157    
Karremann M, Rausche U, Fleischhack G, Nathrath M, Pietsch T, Kramm CM, Wolff JE Clinical and epidemiological characteristics of pediatric gliosarcomas. Journal of neuro-oncology 2010, 97: 257    
Karremann M, Rausche U, Roth D, Kühn A, Pietsch T, Gielen GH, Warmuth-Metz M, Kortmann RD, Straeter R, Gnekow A, Wolff JE, Kramm CM Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. British journal of cancer 2013, epub ahead of print    
Karawajew L, Dworzak M, Ratei R, Rhein P, Gaipa G, Buldini B, Basso G, Hrusak O, Ludwig WD, Henze G, Seeger K, von Stackelberg A, Mejstrikova E, Eckert C Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia. Haematologica 2015, 100: 935    
Karremann M, Krämer N, Hoffmann M, Wiese M, Beilken A, Corbacioglu S, Dilloo D, Driever PH, Scheurlen W, Kulozik A, Gielen GH, von Bueren AO, Dürken M, Kramm CM Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. European journal of cancer (Oxford, England : 1990) 2017, 81: 1    
Karremann M, Gielen GH, Hoffmann M, Wiese M, Colditz N, Warmuth-Metz M, Bison B, Claviez A, van Vuurden DG, von Bueren AO, Gessi M, Kühnle I, Hans VH, Benesch M, Sturm D, Kortmann RD, Waha A, Pietsch T, Kramm CM Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro-oncology 2018 Jan 10; 20: 123    
Kassim AA, Galadanci NA, Pruthi S, DeBaun MR How I treat and manage strokes in sickle cell disease. Blood 2015, 125: 3401    
Kaspers G, Zwaan M, Creutzig U, Ritter J, Rottier M, Pieters R, Veerman A In vitro drug resistance in childhood acute myeloid leukemia. Haematology and Blood Transfusion 1997, 39: 491    
Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering ER, Van Der Does-Van Den Berg A In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997, 90: 2723    
Kaspers G, Zwaan C, Veerman A, Rots M, Pieters R, Bucsky P, Domula M, Göbel U, Graf N, Havers W, Jorch N, Kabisch K, Spaar H, Ritter J, Creutzig U Cellular drug resistance in acute myeloid leukemia. Klin Pädiatr 1999, 211: 239    
Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison LL, Baker KS Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 2009 Dec 15; 115: 5817    
Kaspers GJ, Zimmermann M, Reinhardt D, Gibson BE, Tamminga RY, Aleinikova O, Armendariz H, Dworzak M, Ha SY, Hasle H, Hovi L, Maschan A, Bertrand Y, Leverger GG, Razzouk BI, Rizzari C, Smisek P, Smith O, Stark B, Creutzig U Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group. J Clin Oncol 2013, 31: 599    
Kaufmann A, Gerber NU, Kandels D, Azizi AA, Schmidt R, Warmuth-Metz M, Pietsch T, Kortmann RD, Gnekow AK, Grotzer MA Management of Primary Tectal Plate Low-Grade Glioma in Pediatric Patients: Results of the Multicenter Treatment Study SIOP-LGG 2004. Neuropediatrics 2018, 49: 314    
Kazanowska B, Reich A, Stegmaier S, Békássy AN, Leuschner I, Chybicka A, Koscielniak E Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children. Fetal and pediatric pathology 2007, 26: 17    
Kebelmann-Betzing C, Körner G, Badiali L, Buchwald D, Möricke A, Korte A, Köchling J, Wu S, Kappelmeier D, Oettel K, Henze G, Seeger K Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL. Cytokine 2001, 13: 39    
Kehrer-Sawatzki H, Kordes U, Seiffert S, Summerer A, Hagel C, Schüller U, Farschtschi S, Schneppenheim R, Bendszus M, Godel T, Mautner VF Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1. Molecular genetics & genomic medicine 2018,    
Keilholz U, Pezzuto A, Eggert A Langfristige, strukturierte Nachsorge nach kurativer Krebsbehandlung essenziell. Dtsch Arztebl Int 2014, 111(1-2): 1    
Kelly P (Hrsg) Viel Liebe gegen Schmerzen. Rowohlt 1986    
Kellie SJ Chemotherapy of central nervous system tumours in infants. Childs Nerv Syst 1999, 592    
Kelly MJ, Pennarola BW, Rodday AM, Parsons SK, on behalf of the Journeys to Recovery Study, the HSCT-CHESS™ Study Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatric blood & cancer 2011 Dec 19;    
Kelley LM, Schlegel M, Hecker-Nolting S, Kevric M, Haller B, Rössig C, Reichardt P, Kager L, Kühne T, Gosheger G, Windhager R, Specht K, Rechl H, Tunn PU, Baumhoer D, Wirth T, Werner M, von Kalle T, Nathrath M, Burdach S, Bielack S, von Lüttichau I Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020, 38: 823    
Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). Journal of clinical oncology 2005, 23: 559    
Kenet G, Lütkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, Chabrier S, Chan A, deVeber G, Fiedler B, Fullerton HJ, Goldenberg NA, Grabowski E, Günther G, Heller C, Holzhauer S, Iorio A, Journeycake J, Junker R, Kirkham FJ, Kurnik K, Lynch JK, Male C, Manco-Johnson M, Mesters R, Monagle P, van Ommen CH, Raffini L, Rostásy K, Simioni P, Sträter RD, Young G, Nowak-Göttl U Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010 Apr 27; 121: 1838    
Kennedy C, Bull K, Chevignard M, Culliford D, Dörr HG, Doz F, Kortmann RD, Lannering B, Massimino M, Navajas Gutiérrez A, Rutkowski S, Spoudeas HA, Calaminus G, PNET4 study group of the Brain Tumour Group of The European branch of the International Society of Paediatric Oncology (SIOP-E) Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma. International journal of radiation oncology, biology, physics 2014, 88: 292    
Kersten W, Brade W [Treatment of bronchitis with cefaclor (Panoral) (author's transl)]. MMW, Munchener medizinische Wochenschrift 1979 Feb 16; 121: 247    
Kern W, Büchner T, Wörmann B, Ritter J, Creutzig U, Hiddemann W Akute Leukämien; Prognostische Faktoren und Therapiestrategien. Internist 1999, 40: 983    
Kersting C, Gebert C, Agelopoulos K, Schmidt H, van Diest PJ, Jürgens H, Winkelmann W, Kevric M, Gosheger G, Brandt B, Bielack S, Buerger H Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome. Clinical cancer research 2007, 13: 2998    
Kehrel BE Platelets: biochemistry and physiology. Hamostaseologie 2008, 28: 289    
Kerl K, Holsten T, Frühwald MC Rhabdoid Tumors: Clinical Approaches and Molecular Targets for Innovative Therapy. Pediatric hematology and oncology 2013, epub ahead of print    
Kerl K, Oyen F, Giannikopoulou D, Rössig C, Rellensmann G, Sandkötter J, Brentrup A, Selzer G, Schneppenheim R, Frühwald MC Rapid Diagnosis of an AT/RT by the Detection of a Heterozygous SMARCB1 Germ Line Deletion in an Infant. Pediatric blood & cancer 2016, 63: 1451    
Kersting J, Ranft A, Bhadri V, Brichard B, Collaud S, Cyprová S, Eich H, Ek T, Gelderblom H, Hardes J, Haveman L, Hartmann W, Hauser P, Heesen P, Jürgens H, Kanerva J, Kühne T, Raciborska A, Rascon J, Rechl V, Streitbürger A, Timmermann B, Uhlenbruch Y, Dirksen U Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma. Advances in radiation oncology 2023, 8: 101269    
Ketteler P, Hülsenbeck I, Frank M, Schmidt B, Jöckel KH, Lohmann DR The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer (Oxford, England : 1990) 2020, 133: 47    
Ketteler P, Hülsenbeck I, Frank M, Schmidt B, Jöckel KH, Lohmann DR The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer (Oxford, England : 1990) 2020, 133: 47    
Khan J, Wei J, Ringner M, Saal L, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu C, Peterson C, Meltzer P Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001, 7: 673    
Khalil MN, Erb N, Khalil PN, Escherich G, Janka-Schaub GE Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005, 821: 105    
Khalil A, Würthwein G, Golitsch J, Hempel G, Fobker M, Gerss J, Möricke A, Zimmermann M, Smisek P, Zucchetti M, Nath C, Attarbaschi A, Von Stackelberg A, Gökbuget N, Rizzari C, Conter V, Schrappe M, Boos J, Lanvers-Kaminsky C Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia. Haematologica 2020,Online ahead of print    
Khanam T, Sandmann S, Seggewiss J, Ruether C, Zimmermann M, Norvil AB, Bartenhagen C, Randau G, Mueller S, Herbrueggen H, Hoffmann P, Herms S, Wei L, Woeste M, Wuensch C, Gowher H, Oschlies I, Klapper W, Woessmann W, Dugas M, Burkhardt B Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance. Blood 2021, 137: 2347    
Kidas E, Möricke A, Beier R, Welte K, Schrappe M, Stanulla M, Grigull L Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study. International journal of hematology 2009, 89: 584    
Deutsches Krebsforschungszentrum Krebsinformationsdienst Radioaktivität und Röntgenstrahlung: Quellen, Risiken, Nutzen. 2019    
Kiefer T, Schlüter S, Bechrakis NE, Bornfeld N, Göricke S, Ketteler P, Ting S, Geismar D, Biewald E Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference Centre. Klinische Monatsblatter fur Augenheilkunde 2021, 238: 788    
Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, Mueller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jimenez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-oncology 2017, 19: 1398    
Kilian A, Aigner A, Simon M, Salchow DJ, Potratz C, Thomale UW, Hernáiz Driever P, Tietze A Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma - a retrospective Magnetic Resonance Imaging study. Journal of neuro-oncology 2022, 156: 589    
Kunz J, Kulozik A Makrozytäre Anämien. In: Niemeyer C, Eggert A. ed. Pädiatrische Hämatologie und Onkologie Springer; 2018 54    
Kircher B, Niederwieser D, Gächter A, Lindner B, Mitterschiffthaler A, Urban C, Greinix H, Peters C, Lätzer K, Gastl G, Nachbaur D T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation. International journal of laboratory hematology 2008, 30: 499    
Kirton A, deVeber G Advances in perinatal ischemic stroke. Pediatric neurology 2009, 40: 205    
Kitao H, Takata M Fanconi anemia: a disorder defective in the DNA damage response. Int J Hematol 2011, 93: 417    
Kivela T Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999, 17: 1829    
Klamt B, Schulze M, Thate C, Mares J, Goetz P, Kodet R, Scheulen W, Weirich A, Graf N, Gessler M Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters. Genes Chromosomes Cancer 1998, 22: 287    
Klamroth R, Holzhauer S, Zimmermann R, Heller C, Kurnik K, Beriate® Pharmacovigilance Group Beriate® P in the treatment of patients with haemophilia A: results of a long-term pharmacovigilance study. Thrombosis research 2014, 134 Suppl 1:S16    
Kleinman GM, Hochberg FH, Richardson EP Jr Systemic metastases from medulloblastoma: report of two cases and review of the literature. Cancer 1981 Nov 15; 48: 2296    
Klein G, Schulz B, Spix C, Kaatsch P Risikoabschätzung für Sekundärmalignome nach Krebs im Kindesalter. Monatsschr Kinderheilkd 2002, 150 : 564    
Klein G, Schulz B, Spix C, Kaatsch P Risikoabschätzung für sekundäre Malignome nach kindlicher Krebserkrankung – bevölkerungsbezogene Analysen des Deutschen Kinderkrebsregisters. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 2002, 2: 109    
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61: 215    
Kleideiter E, Schwab M, Friedrich U, Koscielniak E, Schafer B, Klotz U Telomerase activity in cell lines of pediatric soft tissue sarcomas. Pediatr Res 2003, 54: 718    
Klein G, Michaelis J, Spix C, Wibbing R, Eggers G, Ritter J, Kaatsch P Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer 2003, 39: 808    
Klein C, Welte K Genetic insights into congenital neutropenia. Clinical reviews in allergy & immunology 2010, 38: 68    
Klemme M, Gerstl L, Weinberger R, Olivieri M, Flemmer A, von Kries R, Felderhoff-Maeuser U, Dzietko M Neonatal Arterial Ischemic Stroke - A Hospital Based Active Surveillance Study in Germany. Klinische Padiatrie 2017, 229: 142    
Klein K, Beverloo HB, Zimmermann M, Raimondi SC, von Neuhoff C, de Haas V, van Weelderen R, Cloos J, Abrahamsson J, Bertrand Y, Dworzak M, Fynn A, Gibson B, Ha SY, Harrison CJ, Hasle H, Elitzur S, Leverger G, Maschan A, Razzouk B, Reinhardt D, Rizzari C, Smisek P, Creutzig U, Kaspers GJL Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study. Pediatric blood & cancer 2022, 69:e29341    
Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, Feine U, Maul F, Waters W, Wehinger H, Niethammer D Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma. Med Pediatr Oncol 1991, 19: 84    
Klingebiel T, Feine U, Treuner J, Reuland P, Handgretinger R, Niethammer D Treatment of neuroblastoma with [131I]metaiodobenzylguanidine. J Nucl Biol Med 1991, 35: 216    
Klingebiel T, Ritter J, Schellong G, Creutzig U, Riehm H, Henze G, Bender-Götze C, Dopfer R, Ebell W, Friedrich W, Haas R, Schmitz N, Stollmann B, Niethammer D Role and perspectives of BMT in AML. 1991, 7: 66    
Klingebiel T, Pertl U, Hess C, Jürgens H, Koscielniak E, Potter R, van Heek-Romanowski R, Rossi R, Schott C, Spaar H, Willnow U, Treuner J Treatment of children with relapsed soft tissue sarcoma. Med Pediatr Oncol 1998, 30: 269    
Klingebiel T Knochenmark- und Stammzelltransplantation, in Gutjahr P: Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 83    
Klingebiel T, E Koscielniak Weichteilsarkome In: Kiess/Merckenschlager/Pfäffle/Siekmeyer:Therapie im Kindes-und Jugendalter. ISBN 3-437-23200-2, im Druck    
Klingebiel T, Koscielniak E Weichteilsarkome, in: Rüben H (Hrsg.): Uroonkologie. Springer Verlag Heidelberg 4. Aufl. 2007, 657    
Klingebiel T, Koscielniak E Weichteilsarkome, in: Kiess W, Merkenschlager A, Pfäffle R, Siekmeyer W (Hrsg.): Therapie in der Kinder- und Jugendmedizin. Elsevier, Urban & Fischer, München Jena 1. Aufl. 2007, 820    
Klingebiel T, Boos J, Beske F, Hallmen E, Int-Veen C, Dantonello T, Treuner J, Gadner H, Marky I, Kazanowska B, Koscielniak E Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatric blood & cancer 2008, 50: 739    
Klingebiel, T Was Hoffnung kosten darf: Ist die Einlagerung von autologem Nabelschnurblut nötig und sinnvoll? Dtsch Arztebl 2009, 106: 829    
Klingebiel T, Cornish J, Labopin M, Locatelli F, Darbyshire P, Handgretinger R, Balduzzi A, Owoc-Lempach J, Fagioli F, Or R, Peters C, Aversa F, Polge E, Dini G, Rocha V, Pediatric Diseases and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT) Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group. Blood 2010, 115: 3437    
Klinger M, Brandl C, Zugmaier G, Hijazi Y, Bargou RC, Topp MS, Gökbuget N, Neumann S, Goebeler M, Viardot A, Stelljes M, Brüggemann M, Hoelzer D, Degenhard E, Nagorsen D, Baeuerle PA, Wolf A, Kufer P Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab. Blood 2012, 119: 6226    
Göbel U, Gortner L (Hrsg) Supplement Zum 80. Geburtstag von Herrn Prof. Riehm. Klin Pädiatr 2013; 225 (Suppl. 1): S1-S98    
Klimenkova O, Ellerbeck W, Klimiankou M, Ünalan M, Kandabarau S, Gigina A, Hussein K, Zeidler C, Welte K, Skokowa J A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood 2014, 123: 1239    
Klimiankou M, Klimenkova O, Uenalan M, Zeidler A, Mellor-Heineke S, Kandabarau S, Skokowa J, Zeidler C, Welte K GM-CSF stimulates granulopoiesis in a congenital neutropenia patient with loss-of-function biallelic heterozygous CSF3R mutations. Blood 2015/126: 1865    
Klimiankou M, Mellor-Heineke S, Klimenkova O, Reinel E, Uenalan M, Kandabarau S, Skokowa J, Welte K, Zeidler C Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML. Blood 2016, 127: 2638    
Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, Müller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jimenez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-oncology 2017 Oct 1; 19: 1398    
Klimiankou M, Uenalan M, Kandabarau S, Nustede R, Steiert I, Mellor-Heineke S, Zeidler C, Skokowa J, Welte K Ultra-Sensitive CSF3R Deep Sequencing in Patients With Severe Congenital Neutropenia. Frontiers in immunology 2019, 10: 116    
Klingebiel T, Jürgens H, Glauche I, Gnekow A, Kandels D, Woessmann W, Schneider DT, Suttorp M [Registries and studies in the Society for Pediatric Oncology and Hematology (GPOH) - What contribution do they make to progress?] Klinische Padiatrie 2020 Apr 20;    
Klinger M, Zugmaier G, Nägele V, Goebeler ME, Brandl C, Stelljes M, Lassmann H, von Stackelberg A, Bargou RC, Kufer P Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events. Cancer research 2020, 80: 91    
Kloos HD [Methods for pain assessment in nursing practice--1]. Kinderkrankenschwester : 2000, 19: 47    
Kloos HD [Methods of pain diagnosis and measurement of pain level in nursing practice. 2]. Kinderkrankenschwester 2000, 19: 107    
Kloos RQ, Pieters R, Escherich G, van der Sluis IM Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation. Pediatric blood & cancer 2016, 63: 1928    
Kloos RQ, Pieters R, Escherich G, van der Sluis IM Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation. Pediatric blood & cancer 2016, 63: 1928    
Klothaki P, Grace R, Eber S, Puzik A, Kunz J, Burdach S, Andres O, Nathrath M, Kollmar N Pyruvatkinasemangel der Erythrozyten in Deutschland - Klinische Merk-male und Lebensqualität der Patienten. Monatsschrift Kinderheilkunde 2021, in print    
Klumper E, Pieters R, Kaspers G, Loonen A, Huismans D, VanZantwijk C, Hählen K, VanWering E, Henze G, Veerman A Cytostatic drug resistance in childhood relapsed acute lymphoblastic leukemia. Haematol Blood Transfus 1994, 36: 291    
Klumper E, Pieters R, Kaspers G, Huismans D, Loonen A, Rottier M, van Wering E, van der Does-van den Berg A, Hählen K, Creutzig U, Veermann A In vitro chemosensitivity assessed with the MTT assay in childhood acute nonlymphoblastic leukemia. Leukemia 1995, 9: 1864    
Klumper E, Pieters R, Veerman A, Huismans D, Loonen A, Hahlen K, Kaspers G, van Wering E, Hartmann R, Henze G In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 1995, 86: 3861    
Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, Pekrun A, Macakova-Reinhardt K, Reinhardt D Treatment and prognostic impact of transient leukemia in neonates with Down's syndrome. Blood 2008, 111: 2991    
Klusmann JH, Li Z, Böhmer K, Maroz A, Koch ML, Emmrich S, Godinho FJ, Orkin SH, Reinhardt D miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes & development 2010, 24: 478    
Klusmann JH, Reinhardt D, Zimmermann M, Kremens B, Vormoor J, Dworzak M, Creutzig U, Klingebiel T The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Haematologica 2012, 97: 21    
Kluge R, Körholz D [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma. Klinische Padiatrie 2011, [Epub ahead of print]    
Klusmann JH, Reinhardt D, Zimmermann M, Kremens B, Vormoor J, Dworzak M, Creutzig U, Klingebiel T The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Haematologica 2012, 97: 21    
Kluge R, Chavdarova L, Hoffmann M, Kobe C, Malkowski B, Montravers F, Kurch L, Georgi T, Dietlein M, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Wilson L, Bergstraesser E, Sabri O, Mauz-Körholz C, Körholz D, Hasenclever D Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma. PloS one 2016, 11:e0149072    
Kluge R, Wittig T, Georgi TW, Kurch L, Sabri O, Wallace WH, Klekawka T, Fernández-Teijeiro A, Ceppi F, Karlén J, Pears J, Cepelová M, Fosså A, Beishuizen A, Hjalgrim LL, Körholz D, Mauz-Körholz C, Hasenclever D Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021, 62: 338    
Knowles DM Inmunodeficiency-associated lymphoproliferative disorders. Mod Pathol 1999, 12: 200    
Knöfler R, Olivieri M, Weickardt S, Eberl W, Streif W, THROMKID Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung eV [First results of the THROMKID study: a quality project for the registration of children und adolescents with hereditary platelet function defects in Germany, Austria, and Switzerland]. Hamostaseologie 2007, 27: 48    
Knöfler R, Streif W Strategies in Clinical and Laboratory Diagnosis of Inherited Platelet Function Disorders in Children. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2010, 37: 231    
Knöfler R, Eberl W, Schulze H, Bakchoul T, Bergmann F, Gehrisch S, Geisen C, Gottstein S, Halimeh S, Harbrecht U, Kappert G, Kirchmaier C, Kehrel B, Lösche W, Krause M, Mahnel R, Meyer O, Pilgrimm AK, Pillitteri D, Rott H, Santoso S, Siegemund A, Schambeck C, Scheer M, Schmugge M, Scholl T, Strauss G, Zieger B, Zotz R, Hermann M, Streif W [Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]. Hamostaseologie 2014, 34: 201    
Knöfler R, Lohse J, Stächele J, Heilmann A, Schwier F, Schmidt U, Erfurt C Significance of platelet function diagnostics for clarification of suspected battered child syndrome. Hamostaseologie 2014, 34 Suppl 1:S53    
Knörr F, Damm-Welk C, Ruf S, Singh VK, Zimmermann M, Reiter A, Woessmann W Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica 2018, 103: 477    
Knörr F, Zimmermann M, Attarbaschi A, Kabíčková E, Maecker-Kolhoff B, Ruf S, Kühnle I, Ebinger M, Garthe AK, Simonitsch-Klupp I, Oschlies I, Klapper W, Burkhardt B, Woessmann W Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma. Haematologica 2021, 106: 3232    
Knörr F, Woessmann W Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma-Response. British journal of haematology 2023, 200: 107    
Koch A, Dörr H, Beyer R, Erhardt J, Fahlbusch R, Dunst J, Beck J Wachstum und Wachstumsstörungen von Kindern nach Therapie eines Medulloblastoms. Monatsschr Kinderheilkd 1994, 142: 884    
Kochling J, Konig-Merediz S, Stripecke R, Buchwald D, Korte A, Von Einsiedel H, Sack F, Henze G, Seeger K, Wittig B, Schmidt M Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides. Clin Cancer Res 2003, 9: 3142    
Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. The Journal of pathology 2004, 204: 546    
Koch A, Waha A, Hartmann W, Hrychyk A, Schuller U, Waha A, Wharton KA Jr, Fuchs SY, von Schweinitz D, Pietsch T Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clinical cancer research 2005, 11: 4295    
Koch C, Samareh B, Morishima T, Mir P, Kanz L, Zeidler C, Skokowa J, Welte K GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling. Annals of hematology 2017, 96: 345    
Koche RP, Rodriguez-Fos E, Helmsauer K, Burkert M, MacArthur IC, Maag J, Chamorro R, Munoz-Perez N, Puiggròs M, Dorado Garcia H, Bei Y, Röefzaad C, Bardinet V, Szymansky A, Winkler A, Thole T, Timme N, Kasack K, Fuchs S, Klironomos F, Thiessen N, Blanc E, Schmelz K, Künkele A, Hundsdörfer P, Rosswog C, Theissen J, Beule D, Deubzer H, Sauer S, Toedling J, Fischer M, Hertwig F, Schwarz RF, Eggert A, Torrents D, Schulte JH, Henssen AG Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma. Nature genetics 2020, 52: 29    
Koch R, Haveman L, Ladenstein R, Brichard B, Jürgens H, Cyprová S, van den Berg H, Hassenpflug W, Raciborska A, Ek T, Baumhoer D, Egerer G, Kager L, Renard M, Hauser P, Burdach S, Bovee JVMG, Hong AM, Reichardt P, Kruseova J, Streitbürger A, Kühne T, Kessler T, Bernkopf M, Butterfaß-Bahloul T, Dhooge C, Bauer S, Kiss J, Paulussen M, Bonar F, Ranft A, Timmermann B, Rascon J, Vieth V, Kanerva J, Faldum A, Hartmann W, Hjorth L, Bhadri VA, Metzler M, Gelderblom H, Dirksen U Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial. Clinical cancer research 2023,    
Körholz D, Wirtz I, Vosberg H, Rüther W, Jürgens H, Göbel U The role of bone scintigraphy in the follow-up of osteogenic sarcoma. Eur J Cancer 1996, 32A: 461    
Körholz D, Kluge R, Wickmann L, Hirsch W, Lüders H, Lotz I, Dannenberg C, Hasenclever D, Dörffel W, Sabri O Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol. Onkologie 2003, 26: 489    
Körholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, Dörffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-Korholz C, Dannenberg C, Potter R, Brosteanu O, Schellong G, Sabri O The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease. Klin Pädiatr 2004, 216: 150    
Körholz D, Mauz-Körholz C, Vordermark D, Kluge R, Dieckmann K Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy. Klinische Padiatrie 2014, 226(6-7): 307    
Körholz D, Mauz-Körholz C Hodgkin-Lymphom. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018, 338    
Körber V, Stainczyk SA, Kurilov R, Henrich KO, Hero B, Brors B, Westermann F, Höfer T Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome. Nature genetics 2023, 55: 619    
Kohne E Diagnostik von Hämoglobinopathien. J Lab Med 2004, 28 , 400    
Kohne E, Kleihauer E Hämoglobinopathien - eine Langzeitstudie über vier Jahrzehnte. Dtsch Arztebl Int 2010, 107: 65    
Konemann S, Bolling T, Schuck A, Malath J, Kolkmeyer A, Horn K, Riesenbeck D, Hesselmann S, Diallo R, Vormoor J, Willich N Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level. Int J Radiat Biol 2003, 79: 181    
Konemann S, Bolling T, Kolkmeyer A, Riesenbeck D, Hesselmann S, Vormoor J, Willich N, Schuck A Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level. Apoptosis 2005, 10: 177    
Kono T, Sakurai H, Groff WF, Chan HH, Takeuchi M, Yamaki T, Soejima K, Nozaki M Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers in surgery and medicine 2006, 38: 112    
Kontny U, Oschlies I, Woessmann W, Burkhardt B, Lisfeld J, Salzburg J, Janda A, Attarbaschi A, Niggli F, Zimmermann M, Reiter A, Klapper W Non-anaplastic peripheral T-cell lymphoma in children and adolescents - a retrospective analysis of the NHL-BFM study group. British journal of haematology 2015, 168: 835    
Kontny U, Franzen S, Behrends U, Bührlen M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L, Leuschner I, Mottaghy FM, Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group. Klinische Padiatrie 2016, 228: 105    
Kook H Fanconi anemia: current management. Hematology 2005, 10 Suppl 1: 108    
Kortmann R, Timmermann B, Becker G, Kühl J, Bamberg M Advances in treatment techniques and time/dose schedules in external radiation therapy of brain tumours in childhood. Klin Pädiatr 1998, 210: 220    
Kortmann R, Timmermann B, Kühl J, Willich N, Flentje M, Meisner C, Bamberg M HIT '91 (prospective, co-operative study for the treatment of malignant brain tumors in childhood). Strahlenther Onkol 1999, 175: 162    
Korte A, Köchling J, Badiali L, Eckert C, Andreae J, Geilen W, Kebelmann-Betzing C, Taube T, Wu S, Henze G, Seeger K Expression analysis and characterization of alternatively spliced transcripts of human IL-7R alpha chain encoding two truncated receptor proteins in relapsed childhood ALL. Cytokine 2000, 12: 1597    
Kortmann R, Klingebiel Th, Timmermann B, Kühl J, Müller S, Göbel U, Bamberg M Aktuelle radioonkologische Strategien bei der Behandlung von malignen Tumoren im Kindesalter. Onkologe 2000, 6: 854    
Kortmann R, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood. Int J Radiat Oncol Biol Phys 2000, 46: 269    
Kortmann R, Kühl J, Timmermann B, Calaminus G, Dieckmann K, Wurm R, Sörensen N, Urban C, Göbel U, Bamberg M Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood. Strahlenther Onkol 2001, 177: 447    
Kortmann R, Timmermann B, Taylor R, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow A, Dieckmann K, Kay S, Bamberg M Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I Strahlenther Onkol 2003, 179: 509    
Kortmann R, Timmermann B, Taylor R, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow A, Dieckmann K, Kay S, Bamberg M Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II. Strahlenther Onkol 2003, 179: 585    
Kortmann RD, Timmermann B, Rutkowski S, Bamberg M Re: B. Beuthien-Baumann, et al. Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy. Strahlenther Onkol 2003;179:819-22. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2004, 180: 245    
Korinthenberg R, Warmuth-Metz M, Rutkowski S Leitsymptome und Diagnostik der Hirntumoren im Kindes- und Jugendalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft (Gemeinsame Leitlinie der Gesellschaft für Neuropädiatrie und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2007    
Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 2010, 28: 3182    
Korinthenberg R, Neuburger D, Nikkhah G, Teske C, Schnabel K, Calaminus G Assessing Quality of Life in Long-Term Survivors after 125I Brachytherapy for Low-Grade Glioma in Childhood. Neuropediatrics 2011, 42: 110    
Kordes U, Flitsch J, Hagel C, Goebell E, Schwarz R, Herberhold T, von Bueren AO, Rutkowski S, Müller HL Ectopic craniopharyngioma. Klin padiatr 2011, 223: 176    
Korinthenberg R, Neuburger D, Trippel M, Ostertag C, Nikkhah G Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas. International journal of radiation oncology, biology, physics 2011 Mar 15; 79: 1131    
Korte E, Schilling R, Balcerek M, Byrne J, Dirksen U, Herrmann G, Kepak T, Klco-Brosius S, Kruseova J, Kunstreich M, Langer T, Panasiuk A, Stefanowicz J, Strauß G, Wiegele K, Borgmann-Staudt A Fertility-Related Wishes and Concerns of Adolescent Cancer Patients and Their Parents. Journal of adolescent and young adult oncology 2020, 9: 55    
Korte E, Schilling R, Balcerek M, Campbell H, Dirksen U, Herrmann G, Kepakova K, Kepak T, Klco-Brosius S, Kruseova J, Kunstreich M, Lackner H, Langer T, Panasiuk A, Stefanowicz J, Strauß G, Ranft A, Byrne J, Goldbeck L, Borgmann-Staudt A Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe. European journal of cancer care 2020, 29:e13279    
Korshunov A, Okonechnikov K, Stichel D, Schrimpf D, Delaidelli A, Tonn S, Mynarek M, Sievers P, Sahm F, Jones DTW, von Deimling A, Pfister SM, Kool M Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression. Acta neuropathologica 2022, 144: 339    
Koscielniak E, Treuner J, Jürgens H, Winkler K, Bürger D, Herbst M, Ritter J, Niethammer D, Müller-Weihrich S, Bernhard G Treatment of soft tissue sarcomas in childhood and adolescence. Klinische Pädiatrie 1991, 203: 211    
Koscielniak E, Jürgens H, Winkler K, Bürger D, Herbst M, Keim M, Bernhard G, Treuner J Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 1992, 70: 2557    
Koscielniak E, Rodary C, Flamant F, Carli M, Treuner J, Pinkerton C, Grotto P Metastatic soft tissue sarcoma in childhood. Med Pediatr Oncol 1992, 209    
Koscielniak E, Rodary C, Flamant F, Carli M, Treuner J, Pinkerton C, Grotto P Metastatic rhabdomyosarcoma and histologically similar tumors in childhood. Med Pediatr Oncol 1992, 20: 209    
Koscielniak E, Hammer S, Blank J Effects of rh-GM-GSF on hematopoietic recovery and infections complications in children with solid tumors after high-dose chemotherapy followed by ABMT. Br J Haematology 1994    
Koscielniak E, Herbst M, Niethammer D, Treuner J Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas. Klinische Pädiatrie 1994, 206: 269    
Koscielniak E, Klingebiel T, Peters C, Hermann J, Burdach S, Bender-Götze C, Müller-Weihrich S, Treuner J Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Bone Marrow Transplant 1997, 19: 227    
Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, Klingebiel T, Schmidt B, Morgan M, Knietig R, Treuner J Results of treatment for soft tissue sarcoma in childhood and adolescence. J Clin Oncol 1999, 17: 3706    
Koscielniak E, Morgan M, Treuner J Soft tissue sarcoma in children. Paediatr Drugs 2002, 4: 21    
Koscielniak E, T Klingebiel, A Schuck, I Leuschner Weichteilsarkome im Kindesalter. Diagnostik und Therapie. Der Onkologe 2005 (electronic on line first article)    
Koscielniak E, Treuner J Weichteilsarkome. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und Leitlinien und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2008    
Koscielniak E, Dantonello T, Klingebiel T Weichteiltumoren – Neue Projekte der CWS-Studiengruppe: das Register „SoTiSaR für Weichteilsarkome und –tumoren sowie die multizentrische Studie CWS-2007-HR zur Behandlung von Patienten mit lokalisierten rhabdomyosarkomartigen Weichteilsarkomen. Wir – die Zeitschrift der Deutschen Leukämie-Forschungshilfe e.V. und der Deutschen Kinderkrebsstiftung 3/2009    
Koscielniak E Weichteilsarkome. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie AWMF online 2011    
Koscielniak E, Fuchs J, Leuschner I, Greulich M, Kllingebiel T Weichteiltumoren. in: Solide Tumoren im Kindesalter. Fuchs J (Hrsg.) Schattauer GmbH Stuttgart 2012, 197    
Koscielniak E, Klingebiel T Weichteilsarkome. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) AWMF    
Koscielniak E, Klingebiel T Weichteilsarkome. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie, Springer-Verlag GmbH Deutschland 2. vollständig überarbeitete Auflage 2018, 475    
Koscielniak E, Klingebiel T A new standard of care for patients with high-risk rhabdomyosarcoma? The Lancet. Oncology 2020, 21:e1    
Koscielniak E, Sparber-Sauer M, Scheer M, Vokuhl C, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Paulussen M, Bielack SS, Seitz G, Fuchs J, Hallmen E, Klingebiel T, On Behalf Of The Cws Study Group Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS). Pediatric blood & cancer 2021,e29145    
Koscielniak E, Blank B, Vokuhl C, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Handgretinger R, Seitz G, Fuchs J, Fröhlich B, Scheer M, Wessalowski R, Schmid I, Sparber-Sauer M, Klingebiel T Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol. Cancers 2022 Feb 11; 14    
Koscielniak E, Blank B, Vokuhl C, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Handgretinger R, Seitz G, Fuchs J, Fröhlich B, Scheer M, Wessalowski R, Schmid I, Sparber-Sauer M, Klingebiel T Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol. Cancers 2022, 14    
Koscielniak E, Timmermann B, Münter M, Weclawek-Tompol J, Ladenstein R, Niggli F, Ljungman G, Brecht IB, Blank B, Hallmen E, Scheer M, Fuchs J, Seitz G, Blattmann C, Sparber-Sauer M, Klingebiel T Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry. Journal of clinical oncology 2023, 41: 4916    
Koustenis E, Pfitzer C, Balcerek M, Reinmuth S, Zynda A, Stromberger C, Hohmann C, Keil T, Borgmann-Staudt A Impact of cranial irradiation and brain tumor location on fertility: a survey. Klinische Padiatrie 2013, 225: 320    
Kovnar E, Kun L, Burger P, et al. Patterns of dissemination and recurrence in childhood ependymoma: Preliminary results of Pediatric Oncology Group Protocol #8532. Ann Neurol 30: 457, 1991    
Kovnar EH Hyperfractionated irradiation for childhood ependymoma: early results of a phase III Pediatric Oncology Group study. VIIth Symposium Pediatric Neurooncology Abstract 31, Washington 1996    
Kovac M, Woolley C, Ribi S, Blattmann C, Roth E, Morini M, Kovacova M, Ameline B, Kulozik A, Bielack S, Hartmann W, Ballinger ML, Thomas DM, Tomlinson I, Nathrath M, Heinimann K, Baumhoer D Germline RET variants underlie a subset of paediatric osteosarcoma. Journal of medical genetics 2021, 58: 20    
Kraus J, Albrecht S, Wiestler O, von Schweinitz D, Pietsch T Loss of heterozygosity on chromosome 1 in human hepatoblastoma. Int J Cancer 1996, 67: 467    
Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification. Cancer 2002, 94: 854    
Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol 2003, 162: 1019    
Krams M, Heidebrecht HJ, Hero B, Berthold F, Harms D, Parwaresch R, Rudolph P Repp86 expression and outcome in patients with neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003, 21: 1810    
Kratz CP, Rogge T, Kopp M, Baumann I, Niemeyer CM Myelodysplastic features in an infant with cystic fibrosis presenting with anaemia, oedema and failure to thrive. European journal of pediatrics 2005, 164: 56    
Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, Emanuel PD, Hasle H, Kardos G, Klein C, Kojima S, Stary J, Trebo M, Zecca M, Gelb BD, Tartaglia M, Loh ML The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 2005, 106: 2183    
Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 2006, 26: 3773    
Kratz CP, Steinemann D, Niemeyer CM, Schlegelberger B, Koscielniak E, Kontny U, Zenker M Uniparental disomy at chromosome 11p15. 5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Human molecular genetics 2007, 16: 374    
Krappmann P, Paulides M, Stöhr W, Ittner E, Plattig B, Nickel P, Lackner H, Schrappe M, Janka G, Beck JD, Langer T Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatric hematology and oncology 2007, 24: 101    
Kramm C, Wolff JEA Hochgradig maligne Gliome und Ponsgliome im Kindes- und Jugendalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie 2008    
Kramm C, Rausche U, Butenhoff S, Kühnöl C, Kunze C, Kortmann R, Wolff J, van Gool S Hochmaligne Gliome im Kindes- und Jugendalter. Monatsschr Kinderheilkd 2008, 156: 1201    
Kramm C Die HIT-HGG-Studiengruppe - Beratung und Protokolle für alle Behandlungssituationen bei hochmalignen Gliomen im Kindes- und Jugendalter. WiR - die Zeitschrift der Deutschen Leukämie-Forschungshilfe e.V. und der Deutschen Kinderkrebsstiftung 1/2010    
Kramm CM, Butenhoff S, Rausche U, Warmuth-Metz M, Kortmann RD, Pietsch T, Gnekow A, Jorch N, Janssen G, Berthold F, Wolff JE Thalamic high-grade gliomas in children: a distinct clinical subset? Neuro Oncol 2011, 13: 680    
Krawczuk-Rybak M, Płonowski M, Solarz E, Sega-Pondel D, Kazanowska B, Zelazowska-Rutkowska B, Wysocka J Assessment of gonadal function in boys and adolescents at the diagnosis of neoplastic disease. Journal of pediatric endocrinology & metabolism : JPEM 2012, 25(5-6): 453    
Kramm C Die neue HIT-HGG-2013-Studie. WIR - Zeitschrift der Deutschen Kinderkrebsstiftung und der Deutschen Leukämie-Forschungshilfe e.V 3/17    
Kramm C, Benesch M Gliome mit hoher Malignität und diffus intrinsische Ponsgliome. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018, 388    
Kränzle S, Schmid U, Seeger C (Hrsg) Palliative Care. Springer 2023, 7. Auflage    
Kremens B, Klingebiel T, Herrmann F, Bender-Gotze C, Burdach S, Ebell W, Friedrich W, Koscielniak E, Schmid H, Siegert W, High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma. Med Pediatr Oncol 1994, 23: 470    
Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws H, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein F, Schulz A, Wawer A, Zintl F, Graf N High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002, 30: 893    
Kremens B, Hero B, Esser J, Weinel P, Filger-Brillinger J, Fleischhack G, Graf N, Gruttner H, Niemeyer C, Schulz A, Wickmann L, Berthold F Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14. 18 for neuroblastoma. Cancer Immunol Immunother 2002, 51: 107    
Kremens B, Wieland R, Reinhard H, Neubert D, Beck JD, Klingebiel T, Bornfeld N, Havers W High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone marrow transplantation 2003, 31: 281    
Kreuter M, Bieker R, Bielack SS, Auras T, Buerger H, Gosheger G, Jürgens H, Berdel WE, Mesters RM Prognostic relevance of increased angiogenesis in osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2004, 10: 8531    
Kreicbergs U, Valdimarsdóttir U, Steineck G, Henter JI A population-based nationwide study of parents' perceptions of a questionnaire on their child's death due to cancer. Lancet (London, England) 2004 Aug 28-Sep 3; 364: 787    
Kreuter M, Paulussen M, Boeckeler J, Gerss J, Buerger H, Liebscher C, Kessler T, Jürgens H, Berdel WE, Mesters RM Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma. European journal of cancer (Oxford, England : 1990) 2006, 42: 1904    
Krentz S, Hof J, Mendioroz A, Vaggopoulou R, Dörge P, Lottaz C, Engelmann JC, Groeneveld TW, Körner G, Seeger K, Hagemeier C, Henze G, Eckert C, von Stackelberg A, Kirschner-Schwabe R Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 2013, 27: 295    
Kreuz W, Rusicke E, Martinez-Saguer I, Aygören-Pürsün E, Heller C, Klingebiel T Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion 2012, 52: 100    
Kreitler S, Weyl Ben- Arush M, Martin A (eds) Pediatric Psycho-oncology. Psychosocial Aspects and Clinical Intervention. Wiley-Blackwell Oxford Second Edition 2012    
Krentz S, Hof J, Mendioroz A, Vaggopoulou R, Dörge P, Lottaz C, Engelmann JC, Groeneveld TW, Körner G, Seeger K, Hagemeier C, Henze G, Eckert C, von Stackelberg A, Kirschner-Schwabe R Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 2013, 27: 295    
Krell PF, Reuther S, Fischer U, Keller T, Weber S, Gombert M, Schuster FR, Asang C, Stepensky P, Strahm B, Meisel R, Stoye J, Borkhardt A Next-generation-sequencing-spectratyping reveals public T-cell receptor repertoires in pediatric very severe aplastic anemia and identifies a beta chain CDR3 sequence associated with hepatitis-induced pathogenesis. Haematologica 2013, Epub ahead of print    
Kremeike K, Juergens C, Alz H, Reinhardt D Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic Leukemia. Klin Pädiatr 2015, 227(6-07): 329    
Kreyer J, Ranft A, Timmermann B, Jürgens H, Jung S, Wiebe K, Boelling T, Schuck A, Vieth V, Streitbuerger A, Hardes J, Heinemann M, Dirksen U Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Pediatric blood & cancer 2018, 65:e27384    
Kreitz K, Ernst A, Schmidt R, Simon T, Fischer M, Volland R, Hero B, Berthold F A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis. Cancer medicine 2019 Oct 20;    
Krewer J, Rolle U, Koscielniak E, Vokuhl C, Mentzel T, Seitz G, Feuchtgruber S, von Kalle T, Scheer M, Münter M, Bielack SS, Fuchs J, Niggli F, Hettmer S, Klingebiel T, Sparber-Sauer M, CWS Study Group Dermatofibrosarcoma protuberans in children and adolescents: Primary and Relapsed disease-Experience of the Cooperative Weichteilsarkomstudiengruppe (CWS). Journal of surgical oncology 2020, 122: 263    
Kresbach C, Dorostkar MM, Suwala AK, Wefers AK, Schweizer L, Engertsberger L, Bison B, Mynarek M, Kloth-Stachnau K, Spohn M, von Deimling A, Benesch M, Hagel C, Mautner VF, Rutkowski S, Schüller U Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype. Acta neuropathologica 2021, 141: 971    
Krieger D, Moericke A, Oschlies I, Zimmermann M, Schrappe M, Reiter A, Burkhardt B Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia. Haematologica 2010, 95: 158    
Krishnamurti L Should young children with sickle cell disease and an available human leukocyte antigen identical sibling donor be offered hematopoietic cell transplantation? Hematol Oncol Stem Cell Ther 2020 Mar 12; ePub    
Hrsg: Kroll T, Petermann F, Wiedebusch S Schmerz im Kindesalter: Verhaltensmedizinische Grundlagen und Anwendungen. 1994    
Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, Annam A, Baker CN, Frommelt PC, Hodak A, Pate BM, Pelletier JL, Sandrock D, Weinberg ST, Whelan MA, SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics 2019, 143    
Kroll M, Kaupat-Bleckmann K, Moerickel A, Altenl J, Schewel DM, Stanullal M, Zimmermann M, Schrappe M, Cario G Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen. Haematologica 2020, 105: 1013    
Knörr F, Woessmann W Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma-Response. British journal of haematology 2023, 200: 107    
Krull KR, Sabin ND, Reddick WE, Zhu L, Armstrong GT, Green DM, Arevalo AR, Krasin MJ, Srivastava DK, Robison LL, Hudson MM Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Oct 10; 30: 3618    
Krull K, Kunstreich M, Bronsema A, Bleckmann K, Classen CF, Erdlenbruch B, Jorch N, Kolb R, Leipold A, Moser O, Prokop A, Scheurlen W, Steinbach D, Klasen-Sansone J, Klee D, Escherich G, Moericke A, Schrappe M, Borkhardt A, Kuhlen M Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy. Leukemia & lymphoma 2019, 60: 78    
Krumbholz M, Eiblwieser J, Ranft A, Zierk J, Schmidkonz C, Stütz AM, Peneder P, Tomazou EM, Agaimy A, Bäuerle T, Hartmann W, Dirksen U, Metzler M Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2021, 27: 5922    
Krzyzankova M, Mertsch S, Koos B, Jeibmann A, Kruse A, Kordes U, Frühwald MC, Wolff JE, Paulus W, Hasselblatt M Loss of TP53 expression in immortalized choroid plexus epithelial cells results in increased resistance to anticancer agents. Journal of neuro-oncology 2012, 109: 449    
Krümpelmann S, Tillmann B, Schulze-Westhoff P, Jürgens H, Boos J Comparison of oral vs. intravenous etoposide. Med Pediatr Oncol 1996, 27    
Kube SJ, Blattmann C, Bielack SS, Kager L, Kaatsch P, Kühne T, Sorg B, Kevric M, Jabar S, Hallmen E, Sparber-Sauer M, Klingebiel T, Koscielniak E, Dirksen U, Hecker-Nolting S, Gerß JWO Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer 2022, 128: 1787    
Kuçi S, Rettinger E, Voss B, Weber G, Stais M, Kreyenberg H, Willasch A, Kuçi Z, Koscielniak E, Klöss S, von Laer D, Klingebiel T, Bader P Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation. Haematologica 95: 1579    
Kühl J Chemotherapy of brain tumors in childhood. Review of the literature and pilot protocol. Klin Pädiatr 1988, 200: 214    
Kühl J, Rating D, Berthold F, Graf N, Maass E, Gnekow A, Weinl P, Göbel U, Havers W, Lakomek M, Gutjahr P, Urban Ch, Bamberg M, Bode U, Kaatsch P, Kleihues P, Niethammer D, Sörensen N Ergebnisse der multizentrischen Chemotherapiepilotstudie HIT '88/'89. Aktuelle Neuropädiatrie 1991 1992, 176    
Kühl J, Berthold M, Bode U, Bucsky P, Graf N, Gnekow A, Maass E, Bamberg M, Kaatsch P, Kleihues P, Rating D, Riehm H, Sörensen N Preradiation chemotherapy of children with poor-prognosis medulloblastoma:response rate and toxicity of the ifosfamide-containing multidrug regimen HIT 88/89. The Am J Pediatr Hematol Oncol 1993, 15: 67    
Kühl J Interdisziplinäre Behandlung von Medulloblastom und PNET. Klinische Onkologie 94/95 (Sonderband der Schweizer Rundschau für Medizin) 1994, 16    
Kühl J Ergebnisse der Pädiatrischen Neuro-Onkologie III, Berichte von der Tagung der Arbeitsgruppe für Hirntumoren im Kindesalter der Gesellschaft für Pädiatrische Onkologie und Hämatologie und der Gesellschaft für Neuropädiatrie am 13./14. Juni 1997 in Würzburg. GPOH 1997    
Kühne T, Freedman J, Semple JW, Doyle J, Butchart S, Blanchette VS Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. The Journal of pediatrics 1997, 130: 17    
Kühl J Modern treatment strategies in medulloblastoma. Childs Nerv Syst 1998, 14: 2    
Kühl J, Muller H, Berthold F, Kortmann R, Deinlein F, Maass E, Graf N, Gnekow A, Scheurlen W, Göbel U, Wolff J, Bamberg M, Kaatsch P, Kleihues P, Rating D, Sörensen N, Wiestler O Preradiation chemotherapy of children and young adults with malignant brain tumors. Klin Pädiatr 1998, 210: 227    
Kühl J, Kortmann R, Pietsch T, Sörensen N, Warmuth-Metz M Medulloblastom. Hämatologie und Onkologie - ODIN-Kompendium Hannover 2000,Onkologisch-hämatologisches Daten- und Informationsnetz, Berlin: HOS-multimedica Health Online Service    
Kühl J Therapie von Kindern mit einem Medulloblastom. WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2001, 4: 8    
Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR, Intercontinental Childhood ITP Study Group Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001, 358: 2122    
Kühl J, Korinthenberg R ZNS-Tumoren. In: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006, 777    
Küper M, Timmann D Cerebellar mutism. Brain and language 2013, 127: 327    
Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. The British journal of ophthalmology 2015,Epub ahead of print    
Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Güngür T, Kropshofer G, Lang P, Lawitschka A, Metzler M, Pentek F, Rossig C, Schlegel PG, Schrappe M, Schrum J, Schulz A, Schwinger W, von Stackelberg A, Strahm B, Suttorp M, Luettichau IT, Wössmann W, Borkhardt A, Meisel R, Poetschger U, Glogova E, Peters C Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial. British journal of haematology 2018, 183: 104    
Kuhlen M, Willasch AM, Dalle JH, Wachowiak J, Yaniv I, Ifversen M, Sedlacek P, Guengoer T, Lang P, Bader P, Sufliarska S, Balduzzi A, Strahm B, von Luettichau I, Hoell JI, Borkhardt A, Klingebiel T, Schrappe M, von Stackelberg A, Glogova E, Poetschger U, Meisel R, Peters C Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial. British journal of haematology 2018, 180: 82    
Kuhlen M, Wieczorek D, Siebert R, Frühwald MC How I approach hereditary cancer predisposition in a child with cancer. Pediatric blood & cancer 2019, 66:e27916    
Kuhlen M, Kunstreich M, Gökbuget N, Escherich G [Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia]. Orthopadie (Heidelberg, Germany) 2022, 51: 792    
Kulozik A Hemoglobin variants and the rarer hemoglobin disorders. In: Lilleyman JS, Hann IM, Blanchette VS (Hrsg.): Pediatric hematology, 2nd ed 1999, p. 231.256    
Kulozik, AE Hemoglobin variants and the rarer hemoglobin disorders. In: Pediatric Hematology, 3rd Edition,Robert J. Arceci (Editor), Ian M. Hann (Editor), Owen P. Smith (Editor), A. Victor Hoffbrand ( 2006    
Kulozik, AE Thalassämien. In: Gadner, H, Gaedicke, G, Niemeyer, C, Ritter, J (Hrsg.): Pädiatrische Hämatologie und Onkologie, Springer Medizin Verlag 2006    
Kulozik AE, Kunz J Anämiediagnostik im Kindesalter. AWMF Leitlinien    
Kulozik E Hämoglobinopathien nehmen zu. Dtsch Arztebl Int 2010; 107: 63    
Kulozik AE, Kunz J Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie. Anämiediagnostik im Kindesalter. AWMF online 2012    
Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ Lessons from a liver hemangioma registry: subtype classification. Journal of pediatric surgery 2012, 47: 165    
Kulkarni AV, Piscione J, Shams I, Bouffet E Long-term quality of life in children treated for posterior fossa brain tumors. Journal of neurosurgery. Pediatrics 2013, 12: 235    
Kulozik AE, Kunz J Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie: Anämiediagnostik im Kindesalter. AWMF online, 2018    
Kun LE, Kovnar EH, Sanford RA Ependymomas in children. Pediatr Neurosci 1988, 14: 57-63. Review    
Kunz JB, Kulozik AE Differentialdiagnose der kindlichen Anämie. Monatsschrift Kinderheilkunde 2012, 4    
Kunz JB, Rausch T, Bandapalli OR, Eilers J, Pechanska P, Schuessele S, Assenov Y, Stütz AM, Kirschner-Schwabe R, Hof J, Eckert C, von Stackelberg A, Schrappe M, Stanulla M, Koehler R, Avigad S, Elitzur S, Handgretinger R, Benes V, Weischenfeldt J, Korbel JO, Muckenthaler MU, Kulozik AE Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation. Haematologica 2015, 100: 1442    
Kunz J, Kulozik A Sichelzellkrankheit. In: Niemeyer C, Eggert A. ed. Pädiatrische Hämatologie und Onkologie Springer; 2018, 65    
Kunz J, Kulozik A Hämolytische Anämien. In: Niemeyer C, Eggert A. ed. Pädiatrische Hämatologie und Onkologie Springer; 2018, 55    
Kunz J, Kulozik A Makrozytäre Anämien. In: Niemeyer C, Eggert A. ed. Pädiatrische Hämatologie und Onkologie Springer; 2018 54    
Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, Beier R, Schenk D, Schneider D, Groß-Wieltsch U, Prokop A, Heine S, Khurana C, Erlacher M, Dürken M, Linke C, Frühwald M, Corbacioglu S, Claviez A, Metzler M, Ebinger M, Full H, Wiesel T, Eberl W, Reinhard H, Tagliaferri L, Allard P, Karapanagiotou-Schenkel I, Rother LM, Beck D, Le Cornet L, Kulozik AE, German Sickle Cell Disease Registry Sickle cell disease in Germany: Results from a national registry. Pediatric blood & cancer 2020, 67:e28130    
Kunz JB, Kulozik AE Gene Therapy of the Hemoglobinopathies. HemaSphere 2020, 4:e479    
Kunz JB, Schlotmann A, Daubenbüchel A, Lobitz S, Jarisch A, Grosse R, Cario H, Oevermann L, Hakimeh D, Tagliaferri L, Kulozik AE Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome. Journal of clinical medicine 2021, 10    
Kuppers R, Klein U, Hansmann ML, Rajewsky K Cellular origin of human B-cell lymphomas. N Engl J Med 1999, 341: 1520    
Kurowski C, Berthold F Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells. Ann Oncol 1998, 9: 1009    
Kurth A, Kreuz W, Scharrer I Die orthopädische Behandlung von muskulo-skelettalen Komplikationen der Hämophilie. Dtsch Ärztebl 2002, 99: A 2928    
Kurnik K, Bidlingmaier C, Olivieri M Hämostaseologie in der Pädiatrie. Hämostaseologie 2016, 36: 109    
Kurz L, Miklyaeva A, Skowron MA, Overbeck N, Poschmann G, Becker T, Eul K, Kurz T, Schönberger S, Calaminus G, Stühler K, Dykhuizen E, Albers P, Nettersheim D ARID1A Regulates Transcription and the Epigenetic Landscape via POLE and DMAP1 while ARID1A Deficiency or Pharmacological Inhibition Sensitizes Germ Cell Tumor Cells to ATR Inhibition. Cancers 2020, 12    
Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R, Bartelt JM, Kunze C, Wohlgemuth WA, Pelz T, Vordermark D, Plößl S, Hasenclever D, Sabri O, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Løndalen AM, Steiner D, Krombach G, Attarbaschi A, Hoffmann M, Ceppi F, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Körholz D, Stoevesandt D Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial. Pediatric blood & cancer 2021, 68:e28903    
Kusch M, Labouvie H, Langer T, Winkler von Mohrenfels U, Topf R, Felder-Puig R, Beck J, Gadner H, Bode U Psychosoziale Folgen von Krebs im Kindes- und Jugendalter. Versorgungsmanagement in Theorie und Praxis 1999, 4: 1    
Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003, 101: 1249    
Köller U, Haas O, Ludwig W, Bartram C, Harbott J, Panzer-Grümayer R, Hansen-Hagge T, Ritter J, Creutzig U, Knapp W, Gadner H Phenotypic and genotypic heterogeneity in infant acute leukemia II. Acute non-lymphoblastic leukemia. Leukemia 1989, 3: 708    
325 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.